CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

T-Cell Acute Lymphocytic Leukemia · Acute Lymphoblastic Leukemia, in Relapse · Refractory Acute Lymphoblastic Leukemia · T-cell Malignancies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Beijing GoBroad Hospital, Beijing, Beijing Municipality, China

  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, Shanghai, Shanghai Municipality, China

  • Shanghai Liquan Hospital, Shanghai, Shanghai Municipality, China

  • The General Hospital of Western Theater Command PLA, Chengdu, Sichuan, China